Cargando…

APOBEC3-Mediated RNA Editing in Breast Cancer is Associated with Heightened Immune Activity and Improved Survival

APOBEC3 enzymes contribute significantly to DNA mutagenesis in cancer. These enzymes are also capable of converting C bases at specific positions of RNAs to U. However, the prevalence and significance of this C-to-U RNA editing in any cancer is currently unknown. We developed a bioinformatics workfl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Asaoka, Mariko, Ishikawa, Takashi, Takabe, Kazuaki, Patnaik, Santosh K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6888598/ https://www.ncbi.nlm.nih.gov/pubmed/31717692 http://dx.doi.org/10.3390/ijms20225621

Ejemplares similares

Neoadjuvant Chemotherapy for Breast Cancer: Past, Present, and Future
por: Asaoka, Mariko, et al.
Publicado: (2020)

Late recurrence of breast cancer is associated with pro-cancerous immune microenvironment in the primary tumor
por: Takeshita, Takashi, et al.
Publicado: (2019)

Biologically Aggressive Phenotype and Anti-cancer Immunity Counterbalance in Breast Cancer with High Mutation Rate
por: Takahashi, Hideo, et al.
Publicado: (2020)

APOBEC3A cytidine deaminase induces RNA editing in monocytes and macrophages
por: Sharma, Shraddha, et al.
Publicado: (2015)

The double-domain cytidine deaminase APOBEC3G is a cellular site-specific RNA editing enzyme
por: Sharma, Shraddha, et al.
Publicado: (2016)

CD8 T Cell Score as a Prognostic Biomarker for Triple Negative Breast Cancer
por: Oshi, Masanori, et al.
Publicado: (2020)

High Expression of microRNA-143 is Associated with Favorable Tumor Immune Microenvironment and Better Survival in Estrogen Receptor Positive Breast Cancer
por: Tokumaru, Yoshihisa, et al.
Publicado: (2020)

Intratumoral Tumor Infiltrating Lymphocytes (TILs) are Associated With Cell Proliferation and Better Survival But Not Always With Chemotherapy Response in Breast Cancer
por: Wu, Rongrong, et al.
Publicado: (2023)

Should we target “intermediate expression” of HER2 in older estrogen receptor positive patients?
por: Tokumaru, Yoshihisa, et al.
Publicado: (2020)

Heightened Negative Affects Associated With Neurotic Personality in Behavioral Addiction
por: Asaoka, Yui, et al.
Publicado: (2020)

NR2F1, a Tumor Dormancy Marker, Is Expressed Predominantly in Cancer-Associated Fibroblasts and Is Associated with Suppressed Breast Cancer Cell Proliferation
por: Wu, Rongrong, et al.
Publicado: (2022)

Abundance of Regulatory T Cell (Treg) as a Predictive Biomarker for Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer
por: Oshi, Masanori, et al.
Publicado: (2020)

Left sided breast cancer is associated with aggressive biology and worse outcomes than right sided breast cancer
por: Abdou, Yara, et al.
Publicado: (2022)

Estrogen Receptor Positive Breast Cancer with High Expression of Androgen Receptor has Less Cytolytic Activity and Worse Response to Neoadjuvant Chemotherapy but Better Survival
por: Okano, Maiko, et al.
Publicado: (2019)

Stem-loop structure preference for site-specific RNA editing by APOBEC3A and APOBEC3G
por: Sharma, Shraddha, et al.
Publicado: (2017)

The Roles of APOBEC-mediated RNA Editing in SARS-CoV-2 Mutations, Replication and Fitness
por: Kim, Kyumin, et al.
Publicado: (2022)

The Roles of APOBEC-mediated RNA Editing in SARS-CoV-2 Mutations, Replication and Fitness
por: Kim, Kyumin, et al.
Publicado: (2022)

The roles of APOBEC-mediated RNA editing in SARS-CoV-2 mutations, replication and fitness
por: Kim, Kyumin, et al.
Publicado: (2022)

M1 Macrophage and M1/M2 ratio defined by transcriptomic signatures resemble only part of their conventional clinical characteristics in breast cancer
por: Oshi, Masanori, et al.
Publicado: (2020)

Enhanced immune response outperform aggressive cancer biology and is associated with better survival in triple-negative breast cancer
por: Oshi, Masanori, et al.
Publicado: (2022)

Altered Expression of Secreted Mediator Genes That Mediate Aggressive Breast Cancer Metastasis to Distant Organs
por: Maiti, Aparna, et al.
Publicado: (2021)

BE-FLARE: a fluorescent reporter of base editing activity reveals editing characteristics of APOBEC3A and APOBEC3B
por: Coelho, Matthew A., et al.
Publicado: (2018)

RNA binding to APOBEC deaminases; Not simply a substrate for C to U editing
por: Smith, Harold C.
Publicado: (2016)

Development of a novel BRCAness score that predicts response to PARP inhibitors
por: Oshi, Masanori, et al.
Publicado: (2022)

Acute expression of human APOBEC3B in mice results in RNA editing and lethality
por: Alonso de la Vega, Alicia, et al.
Publicado: (2023)

APOBEC1 mediated C-to-U RNA editing: target sequence and trans-acting factor contribution to 177 RNA editing events in 119 murine transcripts in vivo
por: Soleymanjahi, Saeed, et al.
Publicado: (2021)

Tamoxifen sensitivity-related microRNA-342 is a useful biomarker for breast cancer survival
por: Young, Jessica, et al.
Publicado: (2017)

Human APOBEC1 cytidine deaminase edits HBV DNA
por: Gonzalez, Minerva Cervantes, et al.
Publicado: (2009)

APOBEC Reporter Systems for Evaluating diNucleotide Editing Levels
por: Rieffer, Amanda E., et al.
Publicado: (2023)

APOBEC3-mediated restriction of RNA virus replication
por: Milewska, Aleksandra, et al.
Publicado: (2018)

Quantification of ongoing APOBEC3A activity in tumor cells by monitoring RNA editing at hotspots
por: Jalili, Pégah, et al.
Publicado: (2020)

Genome-wide identification and functional analysis of Apobec-1-mediated C-to-U RNA editing in mouse small intestine and liver
por: Blanc, Valerie, et al.
Publicado: (2014)

Genetic Editing of HBV DNA by Monodomain Human APOBEC3 Cytidine Deaminases and the Recombinant Nature of APOBEC3G
por: Henry, Michel, et al.
Publicado: (2009)

Prognostic value, immune signature and molecular mechanisms of the APOBEC family members APOBEC1, APOBEC3A, APOBEC3G and APOBEC3H in pancreatic adenocarcinoma
por: Duan, Yunjie, et al.
Publicado: (2022)

APOBEC-mediated mutagenesis in urothelial carcinoma is associated with improved survival, mutations in DNA damage response genes, and immune response
por: Glaser, Alexander P., et al.
Publicado: (2017)

Octogenarians’ Breast Cancer Is Associated with an Unfavorable Tumor Immune Microenvironment and Worse Disease-Free Survival
por: Okano, Maiko, et al.
Publicado: (2021)

Decreased Lipid Phosphate Phosphatase 1/3 and Increased Lipid Phosphate Phosphatase 2 Expression in the Human Breast Cancer Tumor Microenvironment Promotes Tumor Progression and Immune System Evasion
por: Benesch, Matthew G. K., et al.
Publicado: (2023)

The Impact of Immunofunctional Phenotyping on the Malfunction of the Cancer Immunity Cycle in Breast Cancer
por: Takeshita, Takashi, et al.
Publicado: (2020)

Massive APOBEC3 Editing of Hepatitis B Viral DNA in Cirrhosis
por: Vartanian, Jean-Pierre, et al.
Publicado: (2010)

Erroneous identification of APOBEC3-edited chromosomal DNA in cancer genomics
por: Suspène, R, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_hoasir1ronq79asdcotq7j9niv